Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.drudis.2021.04.020 http://scihub22266oqcxt.onion/10.1016/j.drudis.2021.04.020 33892148!8057929!33892148     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drug+Discov+Today 2021 ; 26 (10): 2269-2281 Nephropedia Template TP {{tp|p=33892148|t=2021. The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects |pdf=|usr=}}{{33892148}} gab.com Text The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects JO: Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=33892148 #FOAvip Coronavirus 2019 (COVID-19) has caused significant disruption to the cell and gene therapy (CGT) industry, which has historically faced substantial complexities in supply of materials, and manufacturing and logistics processes. As decision-makers shifted their priorities to COVID-19-related issues, the challenges in market authorisation, and price and reimbursement of CGTs were amplified. Nevertheless, it is encouraging to see that some CGT developers are adapting their efforts toward the development of promising COVID-19-related therapeutics and vaccines. Manufacturing resilience, digitalisation, telemedicine, value-based pricing, and innovative payment mechanisms will be increasingly harnessed to ensure that market access of CGTs is not severely disrupted. Twit Text FOAVip The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects ????Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=33892148 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33892148 #FOAvip English Wikipedia <ref>{{Cite pmid|33892148}}</ref> The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects #MMPMID33892148 Qiu T; Wang Y; Liang S; Han R; Toumi M Drug Discov Today 2021[Oct]; 26 (10): 2269-2281 PMID33892148show ga Coronavirus 2019 (COVID-19) has caused significant disruption to the cell and gene therapy (CGT) industry, which has historically faced substantial complexities in supply of materials, and manufacturing and logistics processes. As decision-makers shifted their priorities to COVID-19-related issues, the challenges in market authorisation, and price and reimbursement of CGTs were amplified. Nevertheless, it is encouraging to see that some CGT developers are adapting their efforts toward the development of promising COVID-19-related therapeutics and vaccines. Manufacturing resilience, digitalisation, telemedicine, value-based pricing, and innovative payment mechanisms will be increasingly harnessed to ensure that market access of CGTs is not severely disrupted. |*COVID-19[MESH] |Cell- and Tissue-Based Therapy/economics/*trends[MESH] |Genetic Therapy/economics/*trends[MESH] |Health Care Sector/economics/*trends[MESH]The impact of COVID-19 on the cell and gene therapies industry: Disrup(epmc).pdf DeepDyve Pubget Overpricing